The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Genetically Modified Organisms & Synthetic Biology

Breathing Engineered Bacteria: A New Approach to Treating Lung Disease
Genetically Modified Organisms & Synthetic Biology

Breathing Engineered Bacteria: A New Approach to Treating Lung Disease

AUG 10, 2026
CRISPR study reveals surprising role of Cas9 as a guardian of bacterial defence
Basic & Discovery Research

CRISPR study reveals surprising role of Cas9 as a guardian of bacterial defence

SEP 11, 2025
SNIPR BIOME Raises EUR 35 Million Series B Financing
Finance

SNIPR BIOME Raises EUR 35 Million Series B Financing

AUG 7, 2025
Florey Biosciences spins out of Harvard Wyss Institute to develop a medical food aimed at managing impacts of antibiotic use
Finance

Florey Biosciences spins out of Harvard Wyss Institute to develop a medical food aimed at managing impacts of antibiotic use

OCT 1, 2024
ZBiotics Raises $12M Series A to bring genetically engineered probiotic products to market
Finance

ZBiotics Raises $12M Series A to bring genetically engineered probiotic products to market

SEP 2, 2024
Ancilia Biosciences Announces Closing of $4.2 Million Financing
Finance

Ancilia Biosciences Announces Closing of $4.2 Million Financing

JUL 18, 2024
SNIPR Biome receives funding for the development of CRISPR-medicines to improve EED in pregnant women
Finance

SNIPR Biome receives funding for the development of CRISPR-medicines to improve EED in pregnant women

JUL 1, 2024
SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients
Clinical & Manufacturing

SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients

APR 22, 2024
Neobe Therapeutics Raises Over $2m For Synthetic Biology Enabled Tumour Microenvironment Remodelling
Finance

Neobe Therapeutics Raises Over $2m For Synthetic Biology Enabled Tumour Microenvironment Remodelling

MAR 1, 2024
Smart skin bacteria are able to secrete and produce molecules to treat acne
Genetically Modified Organisms & Synthetic Biology

Smart skin bacteria are able to secrete and produce molecules to treat acne

JAN 11, 2024
Engineered bacteria guide CAR-T cells to poorly infiltrated solid tumors
Genetically Modified Organisms & Synthetic Biology

Engineered bacteria guide CAR-T cells to poorly infiltrated solid tumors

NOV 6, 2023